Psoriasis is a chronic systemic inflammatory disease that primarily affects the skin and is
associated with multiple comorbidities with a considerable reduction in quality of life of …

Background: The management of psoriatic disease in HIV-positive patients is challenging.
Psoriasis in HIV-positive patients is often severe, progressive, and resistant to first-and …

Introduction The benefit/risk profiles of biologics can be affected by comorbidities, certain
demographic characteristics, and concomitant medications; therefore, it is important to …

Background Psoriasis is a chronic immune‐mediated inflammatory disorder that also occurs
in the setting of human immunodeficiency virus (HIV). Biological therapy has transformed the …

The aim of this study is to investigate the demographic and clinical characteristics of patients
receiving biological therapy for psoriasis. All patients who received biological treatment for …

Immunobiologicals represent an innovative therapeutic option in dermatology. They are
indicated in severe and refractory cases of different diseases when there is contraindication …

The management of psoriasis in individuals with human immunodeficiency virus (HIV)
presents a unique challenge, marked by a more severe progression and limited efficacy of …

Psoriasis is a dermatological, chronic, immune-mediated condition. Psoriasis symptoms are
not associated with physical burden only, but it may also have psychosocial effects on …

Abstract Most patients (92.9%, IP i < 0.001) showed no exacerbation of psoriasis during
follow-up, with four patients experiencing worsening of psoriasis symptoms during the study …

Abstract Dear Editor, Patients with psoriasis and/or receiving treatment for psoriasis have an
increased risk of cancer. In particular, a patient experienced relapses of his urinary bladder …